HomeInsightsStock Comparison

Aarti Drugs Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Aarti Drugs Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Last Updated on: Jun 13, 2025

Key Highlights

  • The Latest Trading Price of Aarti Drugs Ltd is ₹ 473.75 as of 12 Jun 15:30.
  • The P/E Ratio of Aarti Drugs Ltd changed from 8.3 on March 2020 to 23.3 on March 2024 . This represents a CAGR of 22.93% over 5 yearsThe P/E Ratio of Solara Active Pharma Sciences Ltd changed from 10.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Aarti Drugs Ltd changed from ₹ 1178 crore on March 2020 to ₹ 3988 crore on March 2024 . This represents a CAGR of 27.61% over 5 yearsThe Market Cap of Solara Active Pharma Sciences Ltd changed from ₹ 1190 crore on March 2020 to ₹ 1340 crore on March 2024 . This represents a CAGR of 2.41% over 5 years.
  • The revenue of Aarti Drugs Ltd for the Mar '25 is ₹ 678.63 crore as compare to the Dec '24 revenue of ₹ 568.5 crore. This represent the growth of 19.37% The revenue of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 278.96 crore as compare to the Dec '24 revenue of ₹ 301.8 crore. This represent the decline of -7.57%.
  • The ebitda of Aarti Drugs Ltd for the Mar '25 is ₹ 95.2 crore as compare to the Dec '24 ebitda of ₹ 73.62 crore. This represent the growth of 29.31% The ebitda of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 51.32 crore as compare to the Dec '24 ebitda of ₹ 59.17 crore. This represent the decline of -13.27%.
  • The net profit of Aarti Drugs Ltd changed from ₹ 47.97 crore to ₹ 62.77 crore over 8 quarters. This represents a CAGR of 14.39% The net profit of Solara Active Pharma Sciences Ltd changed from ₹ -19.11 crore to ₹ -2.1 crore over 8 quarters. This represents a CAGR of -66.85% .
  • The Dividend Payout of Aarti Drugs Ltd changed from 3.43 % on March 2020 to 6.48 % on March 2024 . This represents a CAGR of 13.57% over 5 yearsThe Dividend Payout of Solara Active Pharma Sciences Ltd changed from 4.77 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aarti Drugs Ltd

  • Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
  • The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
  • With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
  • It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
  • It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

About Solara Active Pharma Sciences Ltd

  • Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
  • The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
  • The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
  • It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches.

Aarti Drugs Ltd News Hub

News

Aarti Drugs to convene board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 6 May 2025. Po...

Read more

30 Apr 2025 11:38

News

Aarti Drugs receives affirmation in credit ratings from ICRA

Aarti Drugs has received reaffirmation in credit rating at ICRA AA-; Stable/ ICRA A1+ for ...

Read more

31 Jan 2025 19:10

News

Aarti Drugs gains as PAT rises to Rs 37 cr in Q3; declares dividend of Re 1/sh

Revenue from operations declined 6.44% to Rs 568.50 crore in third quarter of FY25 as comp...

Read more

30 Jan 2025 12:14

News

Board of Aarti Drugs recommends Interim Dividend

Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 29...

Read more

29 Jan 2025 17:03

News

Aarti Drugs to conduct board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 29 January 202...

Read more

23 Jan 2025 11:25

News

Aarti Drugs's receives Establishment Inspection Report for API manufacturing unit

Aarti Drugs has received Establishment Inspection Report (EIR) from USFDA concluding the i...

Read more

24 Dec 2024 15:12

Solara Active Pharma Sciences Ltd News Hub

News

Solara Active Pharma's Ambernath facility clears USFDA inspection

The Agency with their designated investigator inspected the facility from 5th to 9th May 2...

Read more

12 May 2025 08:36

News

Solara Active Pharma Sciences to conduct board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

07 May 2025 17:24

News

Solara Active Pharma Sciences to convene board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

27 Mar 2025 10:23

News

Solara Active Pharma Sciences to hold board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

22 Mar 2025 10:11

News

Solara Active Pharma Sciences to incorporate wholly owned subsidiary

Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in rel...

Read more

07 Feb 2025 11:00

News

Solara Active Pharma Sciences announces board meeting date

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

16 Jan 2025 16:10

SWOT Analysis Of Solara Active Pharma Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Solara Active Pharma Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aarti Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aarti Drugs Ltd and Solara Active Pharma Sciences Ltd

Which company has a larger market capitalization, Aarti Drugs Ltd or Solara Active Pharma Sciences Ltd?

Market cap of Aarti Drugs Ltd is 4,355 Cr while Market cap of Solara Active Pharma Sciences Ltd is 2,251 Cr

What are the key factors driving the stock performance of Aarti Drugs Ltd and Solara Active Pharma Sciences Ltd?

The stock performance of Aarti Drugs Ltd and Solara Active Pharma Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Drugs Ltd and Solara Active Pharma Sciences Ltd?

As of June 13, 2025, the Aarti Drugs Ltd stock price is INR ₹473.75. On the other hand, Solara Active Pharma Sciences Ltd stock price is INR ₹508.3.

How do dividend payouts of Aarti Drugs Ltd and Solara Active Pharma Sciences Ltd compare?

To compare the dividend payouts of Aarti Drugs Ltd and Solara Active Pharma Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions